共 5 条
[1]
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
[J].
ANNALS OF THE RHEUMATIC DISEASES,
2008, 67 (11)
:1516-1523
[4]
Valentincic NV, 2011, MOL VIS, V17, P2003